Status:
COMPLETED
RCT of Cognitive Therapy, Paroxetine, Combined CT and Paroxetine and Placebo
Lead Sponsor:
Norwegian University of Science and Technology
Collaborating Sponsors:
St. Olavs Hospital
Conditions:
Phobic Disorders
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
We aim to (1) evaluate the effectiveness of cognitive therapy and paroxetine and their combination, (2) investigate the patterns of change and the mechanisms of action involved during treatment by usi...
Eligibility Criteria
Inclusion
- Signed written informed consent obtained prior to entry in the study.
- Diagnosed with primary social phobia, generalized or specific (DSM-IV, APA, 1994).
- Symptoms present at least one year.
- Age between 18-65 years.
Exclusion
- Known somatic diseases.
- Pregnant (\*) or lactating women.
- Psychosis
- Acute suicidal symptoms
- Major depressive disorder
- Generalized Anxiety Disorder or PTSD
- Cluster A or cluster B personality disorder
- Substance abuse or dependence
- Body dysmorphic disorder.
- Not willing to accept random allocation.
- Patients who take some form of SSRI medications currently or during the last 6 months
- Patients not willing to withdraw psychotropic medication for a period of 4 weeks prior to entry to the trial or are taking herbal remedies that may be hazardous or inflict treatment response.
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT00184106
Start Date
October 1 2004
End Date
December 1 2010
Last Update
August 27 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of Psychology, NTNU
Trondheim, Dragvoll, Norway, 7491